Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
afatinib (gilotrif) (1 trial)
osimertinib (tagrisso) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Trials (1 total)
Trial APIs (2 total)